ERS 2023 Insights

 

ERS 2023 Insights
O

ERS 2023 Insights: Are Approved PAH Drugs Disease-Modifying?

By ERS 2023 Insights FEATURING Olivier Sitbon
By ERS 2023 Insights FEATURING Olivier Sitbon
0 views
October 4, 2023
Comments 0
Login to view comments. Click here to Login
Videos
22:58
ERS 2023 Insights

ERS 2023 Insights: Sarcoidosis - When Is HRCT Not Enough and When Sh…

Feat. A. Tarnoki
15:05
ERS 2023 Insights

ERS 2023 Insights: Novel Immune Mechanisms of COPD Initiation and Pr…

Feat. F. Polverino
22:24
ERS 2023 Insights

ERS 2023 Insights: Pharmacological Treatment and Current Controversi…

Feat. K. Kostikas
17:18
ERS 2023 Insights

ERS 2023 Insights: Novel Methods of Symptom Monitoring and Managemen…

Feat. K. Ilene Aronson
13:43
ERS 2023 Insights

ERS 2023 Insights: Are Approved PAH Drugs Disease-Modifying?

Feat. O. Sitbon
11:04
ERS 2023 Insights

ERS 2023 Insights: Post Hoc Analyses of Senolytic Pilot Trials in Id…

Feat. D. Kellogg
08:11
ERS 2023 Insights

ERS 2023 Insights: A Long-Term Follow-Up Study of Sotatercept for Pu…

Feat. I. Preston
12:01
ERS 2023 Insights

ERS 2023 Insights: Different Thrombus Recanalization Strategies in P…

Feat. D. Jimenez
13:29
ERS 2023 Insights

ERS 2023 Insights: Obstructive Sleep Apnea and Pulmonary Embolism - …

Feat. A. Ortega
07:13
ERS 2023 Insights

ERS 2023 Insights: Blood Eosinophil Count Measured Before Starting I…

Feat. A. Mathioudakis
18:39
ERS 2023 Insights

ERS 2023 Insights: Is Vaping an Effective (and Safe) Aid for Quittin…

Feat. P. Hajek
16:36
ERS 2023 Insights

ERS 2023 Insights: Defining Disease Modification in PAH

Feat. S. Sahay
12:50
ERS 2023 Insights

ERS 2023 Insights: Management of Dyspnea in ILD

Feat. Y. Khor
21:38
ERS 2023 Insights

ERS 2023 Insights: Should β-Blockers Be Used in Patients With Chroni…

Feat. A. Kaplan
12:58
ERS 2023 Insights

ERS 2023 Insights: Evolution in GOLD - We Cannot "See" &qu…

Feat. A. Anzueto